X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (716) 716
Publication (77) 77
Book Chapter (6) 6
Book Review (6) 6
Conference Proceeding (3) 3
Book / eBook (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (548) 548
index medicus (436) 436
atypical hemolytic uremic syndrome (413) 413
eculizumab (290) 290
female (280) 280
urology & nephrology (234) 234
male (232) 232
antibodies, monoclonal, humanized - therapeutic use (205) 205
hemolytic-uremic syndrome (205) 205
thrombotic microangiopathy (172) 172
complement (162) 162
adult (153) 153
pediatrics (149) 149
mutation (138) 138
mutations (131) 131
child (128) 128
atypical hemolytic uremic syndrome - drug therapy (127) 127
thrombotic thrombocytopenic purpura (125) 125
plasma exchange (119) 119
medicine & public health (108) 108
treatment outcome (108) 108
kidney transplantation (105) 105
nephrology (103) 103
hematology (99) 99
atypical hemolytic uremic syndrome - diagnosis (98) 98
hemolytic uremic syndrome (92) 92
infant (92) 92
ahus (89) 89
child, preschool (89) 89
hemolytic-uremic syndrome - therapy (89) 89
complement factor h - genetics (87) 87
recurrence (87) 87
transplantation (87) 87
hemolytic-uremic syndrome - genetics (86) 86
atypical hemolytic uremic syndrome - therapy (83) 83
care and treatment (79) 79
middle aged (78) 78
adolescent (77) 77
children (76) 76
atypical hemolytic uremic syndrome - genetics (74) 74
diagnosis (73) 73
hemic and lymphatic diseases (69) 69
immunology (69) 69
urologic and male genital diseases (69) 69
complement activation (62) 62
hemolytic-uremic syndrome - diagnosis (61) 61
impact (61) 61
young adult (60) 60
complement factor h (58) 58
risk factors (58) 58
atypical hemolytic uremic syndrome - immunology (56) 56
hemolytic-uremic syndrome - drug therapy (56) 56
hemolytic-uremic syndrome - immunology (56) 56
activation (51) 51
disease (51) 51
membrane cofactor protein (51) 51
pregnancy (51) 51
complement inhibitor eculizumab (50) 50
alternative pathway (49) 49
diagnosis, differential (49) 49
health aspects (49) 49
kidneys (49) 49
anemia (48) 48
atypical haemolytic uraemic syndrome (48) 48
medicine, general & internal (48) 48
research (48) 48
atypical hemolytic uremic syndrome - etiology (46) 46
thrombocytopenic purpura (46) 46
aged (45) 45
abridged index medicus (44) 44
patients (44) 44
autoantibodies (43) 43
complement system proteins - genetics (43) 43
case report (41) 41
complement inactivating agents - therapeutic use (41) 41
antibodies, monoclonal, humanized - administration & dosage (40) 40
deficiency (40) 40
paroxysmal-nocturnal hemoglobinuria (40) 40
atypical hemolytic uremic syndrome - complications (39) 39
atypical hus (39) 39
complement factor h - immunology (39) 39
factor-i (39) 39
monoclonal antibodies (39) 39
prognosis (39) 39
renal-transplantation (39) 39
complement factor-h (38) 38
hus (37) 37
retrospective studies (37) 37
acute kidney injury (36) 36
factor-h (36) 36
therapy (36) 36
urology (36) 36
membranoproliferative glomerulonephritis (35) 35
analysis (34) 34
genetic aspects (33) 33
genetic predisposition to disease (33) 33
hemolytic-uremic syndrome - complications (33) 33
immunosuppressive agents - therapeutic use (33) 33
kidney diseases (33) 33
renal dialysis (33) 33
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (675) 675
Japanese (11) 11
Spanish (10) 10
French (6) 6
German (5) 5
Russian (4) 4
Italian (3) 3
Swedish (3) 3
Polish (2) 2
Portuguese (2) 2
Chinese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Orphanet Journal of Rare Diseases, ISSN 1750-1172, 2011, Volume 6, Issue 1, pp. 60 - 60
Hemolytic uremic syndrome (HUS) is defined by the triad of mechanical hemolytic anemia, thrombocytopenia and renal impairment. Atypical HUS (aHUS) defines non... 
Plasma exchange | Factor H | Combined liver-kidney transplantation | Plasma infusion | Factor B | Atypical hemolytic uremic syndrome | Eculizumab | Membrane cofactor protein | Thrombomodulin | Factor I | Kidney transplantation | MEDICINE, RESEARCH & EXPERIMENTAL | factor I | CFHR1/CFHR3 DEFICIENCY | LIVER-KIDNEY TRANSPLANTATION | plasma infusion | kidney transplantation | eculizumab | factor B | THROMBOTIC THROMBOCYTOPENIC PURPURA | SUCCESSFUL RENAL-TRANSPLANTATION | factor H | combined liver-kidney transplantation | INHIBITOR ECULIZUMAB | ALTERNATIVE PATHWAY | membrane cofactor protein | thrombomodulin | GENETICS & HEREDITY | plasma exchange | SUCCESSFUL PLASMA THERAPY | FACTOR-I MUTATIONS | COMPLEMENT-FACTOR-H | Complement Activation | Humans | Middle Aged | Child, Preschool | Complement System Proteins - immunology | Infant | Male | Hemolytic-Uremic Syndrome - epidemiology | Young Adult | Hemolytic-Uremic Syndrome - genetics | Hemolytic-Uremic Syndrome - physiopathology | Aged, 80 and over | Adult | Complement System Proteins - genetics | Female | Hemolytic-Uremic Syndrome - therapy | Child | Infant, Newborn | Risk Factors | Kidney Transplantation | Animals | Adolescent | Aged | Mice | Mutation | Atypical Hemolytic Uremic Syndrome | Viral antibodies | Usage | Care and treatment | Antibodies | Genetic aspects | Research | Diagnosis | Health aspects | Genetic screening | Hemolytic-uremic syndrome | Risk factors | Lupus | Plasma | E coli | Disease | Vascular endothelial growth factor | Streptococcus infections
Journal Article
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 2017, Volume 12, Issue 8, pp. 1237 - 1247
Background Pregnancy is associated with various forms of thrombotic microangiopathy, including hemolytic uremic syndrome. A previous small French study... 
COFACTOR PROTEIN CD46 | AUTOANTIBODIES | FETOMATERNAL INTERFACE | CELLS | FACTOR-H MUTATIONS | GENE | RARE | COMPLEMENT INHIBITOR ECULIZUMAB | UROLOGY & NEPHROLOGY | DECAY-ACCELERATING FACTOR | Recurrence | Renal Insufficiency, Chronic - etiology | Humans | Middle Aged | Postpartum Period | Plasma Exchange | Genetic Variation | Young Adult | Hemolytic-Uremic Syndrome - genetics | Time Factors | Adult | Female | Hemolytic-Uremic Syndrome - therapy | Retrospective Studies | Complement Activation - drug effects | Genetic Predisposition to Disease | Antibodies, Monoclonal, Humanized - therapeutic use | Hemolytic-Uremic Syndrome - complications | Europe | Complement Factor I - genetics | Treatment Outcome | Hemolytic-Uremic Syndrome - immunology | Disease Progression | Pregnancy | Complement Activation - genetics | Phenotype | Adolescent | Complement Inactivating Agents - therapeutic use | Pregnancy Complications - genetics | Complement Factor H - genetics | Kidney Failure, Chronic - etiology | Pregnancy Complications - immunology | Pregnancy Complications - therapy | Renal Dialysis | chemotactic factor inactivator | Follow-Up Studies | pregnancy | kidney transplantation | Thrombotic Microangiopathies | United Kingdom | eculizumab | hemolytic uremic syndrome | Antibodies, Monoclonal, Humanized | Italy | Kidney Failure, Chronic | thrombotic microangiopathy | complement | Complement Pathway, Alternative | France | Original | Atypical Hemolytic Uremic Syndrome | renal dialysis
Journal Article
Journal Article
Kidney International, ISSN 0085-2538, 02/2018, Volume 93, Issue 2, pp. 450 - 459
Pregnancy-associated atypical hemolytic uremic syndrome (aHUS) refers to the thrombotic microangiopathy resulting from uncontrolled complement activation... 
postpartum | cesarean section | eculizumab | complement | hemolytic uremic syndrome | GENE-MUTATIONS | SYSTEM | ACTIVATION | COMPLEMENT INHIBITOR ECULIZUMAB | PREECLAMPSIA | PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA | THROMBOTIC MICROANGIOPATHY | UROLOGY & NEPHROLOGY | OUTCOMES | AHUS | Complement Activation | Humans | Immunosuppressive Agents - therapeutic use | Complement C3b Inactivator Proteins - genetics | Atypical Hemolytic Uremic Syndrome - immunology | Postpartum Period | Plasma Exchange | Thrombotic Microangiopathies - epidemiology | Thrombotic Microangiopathies - genetics | Adult | Female | Registries | Retrospective Studies | Atypical Hemolytic Uremic Syndrome - genetics | Parity | Thrombotic Microangiopathies - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Atypical Hemolytic Uremic Syndrome - therapy | Risk Factors | Atypical Hemolytic Uremic Syndrome - epidemiology | Treatment Outcome | Gene Conversion | Pregnancy | Cesarean Section | Spain - epidemiology | Pregnancy Complications - genetics | Thrombotic Microangiopathies - therapy | Mutation | Complement Factor H - genetics | Pregnancy Complications - epidemiology | Pregnancy Complications - immunology | Pregnancy Complications - therapy | Renal Dialysis | Thrombotic microangiopathy | Complement activation | Hemolytic uremic syndrome | Hemodialysis | Pregnancy complications | Gene conversion | Patients | Cesarean section | Postpartum
Journal Article
Pediatric Nephrology, ISSN 0931-041X, 2009, Volume 24, Issue 4, pp. 687 - 696
Journal Article
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 03/2013, Volume 13, Issue 3, pp. 663 - 675
Atypical hemolytic and uremic syndrome (aHUS) is a severe disease strongly associated with genetic abnormalities in the complement alternative pathway. In... 
Acute rejection | endothelial cell damage | mutations and polymorphisms in complement alternative pathway | thrombotic microangiopathy | atypical hemolytic and uremic syndrome | renal transplantation | SURGERY | FACTOR-B | HUS | FACTOR-I | FACTOR-H-AUTOANTIBODIES | TRANSPLANTATION | KIDNEY-TRANSPLANTATION | MUTATIONS | CD46 | PREDISPOSE | MEMBRANE COFACTOR PROTEIN | Recurrence | Genetic Testing | Prognosis | Humans | Middle Aged | Male | Young Adult | Hemolytic-Uremic Syndrome - genetics | Complement Factor B - genetics | Adult | Complement System Proteins - genetics | Female | Hemolytic-Uremic Syndrome - therapy | Retrospective Studies | Complement C3 - genetics | Biomarkers - metabolism | Risk Factors | Biomarkers - analysis | Kidney Transplantation | Mutation - genetics | Fibrinogen - genetics | Graft Survival - genetics | Adolescent | Membrane Cofactor Protein - genetics | Aged | Complement Factor H - genetics | Graft Rejection - genetics | Atypical Hemolytic Uremic Syndrome | Medical research | Kidneys | Genes | Organ transplant recipients | Medicine, Experimental | Genetic research | Transplantation | Clinical trials | Mutation | Transplants & implants | Drug therapy | Biological Markers | Complement C3 | Life Sciences | Immunology | Fibrinogen | Hemolytic-Uremic Syndrome | Antigens, CD46 | Graft Survival | Complement Factor H | Complement System Proteins | Complement Factor B | Graft Rejection
Journal Article